TalkSooner and Baldwin Community School collaborate on youth vaping education

Sep.02.2022
TalkSooner and Baldwin Community School collaborate on youth vaping education
TalkSooner works with Michigan schools to educate parents and teens about the dangers and risks of electronic cigarette addiction.

As the number of teenagers vaping across the United States continues to rise, many school districts in West Michigan are taking measures to educate families about the dangers of addiction, including the Baldwin Community Schools.


TalkSooner is an organization dedicated to helping parents and teenagers understand the dangers of drug abuse. They are currently working in collaboration with Baldwin School to educate and facilitate discussions on the topic of teen use of electronic cigarettes.


This organization is a cooperative organization between Allegan County, Berrien County, Kent County, Muskegon County, and Ottawa County in western Michigan. It is coordinated by the West Michigan Shoreline Regional Development Commission (now known as the West Michigan Shoreline Regional Entity).


Recently, the organization partnered with the Baldwin Community School to launch a new education tool that will serve those who can provide information on e-cigarette use for teenagers.


This vehicle made its debut in the area on August 24th. The car displays information in English on one side and in Spanish on the other side through TalkSooner.


According to data from the 2018 National Youth Tobacco Survey (NYTS), the use of electronic cigarettes among current middle and high school students increased by 48% between 2017 and 2018. As of 2018, over 3.6 million children are currently using electronic cigarettes.


Griffin stated, "If you look at smoking, we almost didn't see the number of people smoking in the 50s and 60s because we not only had prevention, but education," Griffin said. "We now know smoking brings harm and can change our lives. We hope to ensure that we take the same measures for children who start vaping at 13 or 14 years old, to catch and quit this habit early or at least make them aware of the dangers that come with it.


On June 4, 2019, Governor Gretchen Whitmer signed Senate Bills 106 and 155, prohibiting the sale and possession of electronic cigarettes to anyone under the age of 18. In December of the same year, federal legislation was signed, raising the legal age to purchase or use tobacco products, including e-cigarettes, to 21. Despite these measures, many remain skeptical of the number of young students still using e-cigarettes.


Griffin has seen firsthand how difficult it is for parents to talk to teenagers about using e-cigarettes after her own child used them. "Preventative education seems to be the most important, not just for your physical health, but also for your mental and overall well-being," she said. "Even in the most educated households, there is still susceptibility to the pressures of e-cigarettes and such. I always encourage parents to have open conversations with their children, discussing their own struggles or choices made by young people. I also suggest trying to find out why they are interested in e-cigarettes or the root cause of their decision to use them.


In September 2018, the US Food and Drug Administration (FDA) sent over 1,300 warning letters and civil monetary penalties to retailers illegally selling e-cigarette products to minors, with the majority being blu, JUUL, Logic, MarkTen XL, and Vuse; this marked the FDA's largest coordinated enforcement effort to date.


According to the Centers for Disease Control and Prevention, some e-cigarette products have labels that do not disclose that they contain nicotine, while some e-cigarette liquids marketed as containing 0% nicotine have been found to contain nicotine.


Using nicotine during adolescence can damage the parts of the brain that control attention, learning, emotions, and impulse control, and may also impair brain development in teenagers. This damage can persist into the mid-20s.


Statement


This article is compiled from third-party information and is intended for industry communication and learning purposes only.


This article does not reflect the views of 2FIRSTS and we cannot verify the accuracy or truthfulness of its contents. The compilation of this article is only intended for industry-related research and exchange.


Due to limitations in the level of translation, the translated article may not express exactly the same meaning as the original. Please refer to the original text for accuracy.


2FIRSTS fully aligns its statements and position with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, or international issues.


The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Texas Extends Tobacco Tax Interpretation to a 6-Methylnicotine Product, Citing VELO Ruling
Texas Extends Tobacco Tax Interpretation to a 6-Methylnicotine Product, Citing VELO Ruling
The Texas Comptroller of Public Accounts ruled in September 2026 that a combustible product made with non-tobacco plant material and 6-methylnicotine (6-MN), a synthetic nicotine analog, qualifies as a taxable tobacco product. The applicant said the product contained neither tobacco leaf nor measurable conventional nicotine. The determination applies reasoning from a May Texas Supreme Court decision involving VELO nicotine pouches, finding that the plant material and 6-MN together perform the functions of tobacco in a conventional smoking product. The ruling carries applicable tax, licensing and reporting obligations but is limited to the facts submitted by the taxpayer. It does not establish a blanket tax classification for all 6-MN products or extend the same conclusion to e-cigarettes.
Regulations
Nov.06
Athletes Back Skoka's $21.5 Million Nicotine Pouch Venture: Can Its Consumer Health Founder Make an FDA-Focused Strategy Pay Off?
Athletes Back Skoka's $21.5 Million Nicotine Pouch Venture: Can Its Consumer Health Founder Make an FDA-Focused Strategy Pay Off?
U.S. nicotine pouch startup Skoka Inc. has raised $21.5 million and committed $15 million to an FDA regulatory and scientific research program. Founder Dan Aziz previously built dietary supplement brand Premama, which was acquired by Dr. Reddy's Laboratories in 2023. Skoka is combining proprietary formulations, ingredient transparency and equity investment from professional athletes. The company submitted a bundled PMTA covering 55 products on October 1, 2026. Aziz said Skoka declined an opportunity to enter retail in 2025, prioritizing product research and regulatory submissions instead. It now targets a U.S. retail launch in 2027, subject to FDA requirements. Its products have not received marketing authorization.
Business
Nov.04
Product | Japan Tobacco Expands Nordic Spirit Nicotine Pouch Range to Eight SKUs in Japan, Launches Melon Variant and Broadens Mint Retail Distribution
Product | Japan Tobacco Expands Nordic Spirit Nicotine Pouch Range to Eight SKUs in Japan, Launches Melon Variant and Broadens Mint Retail Distribution
Japan Tobacco Inc. (JT) launched Nordic Spirit Rich Melon Medium through selected tobacco retailers in Japan on November 2, 2026, while expanding physical retail distribution for three existing mint products previously sold through the CLUB JT online store. The melon launch brings Nordic Spirit's Japanese portfolio to eight SKUs. All four products are manufactured in Sweden, contain a standard 14 pouches per can and retail for ¥500 including tax. Since introducing Nordic Spirit in Japan in March, JT has expanded the brand's product lineup and distribution through its online store, convenience stores and selected tobacco retailers.
product
Nov.04
US ITC Judge Finds Glas Infringed Two JUUL Vape Patents, Recommends Restrictions on Related Imports——Glas Received FDA Marketing Authorization for Four Vape Pods in May 2026; Proposed Restrictions Remain Under Commission Review
US ITC Judge Finds Glas Infringed Two JUUL Vape Patents, Recommends Restrictions on Related Imports——Glas Received FDA Marketing Authorization for Four Vape Pods in May 2026; Proposed Restrictions Remain Under Commission Review
A U.S. International Trade Commission (USITC) administrative law judge issued an initial determination on October 20, 2026, finding that certain Glas vaping devices, cartridges and components infringed 12 claims across two patents asserted by JUUL, constituting a violation of Section 337 of the Tariff Act of 1930. The judge recommended a limited exclusion order and a cease and desist order against the Glas respondents. Five months earlier, the FDA authorized four Glas e-cigarette pods, including mango, blueberry and two menthol variants. The patent investigation concerns device and cartridge structures and is separate from FDA premarket review. The proposed import restrictions have not become final, and their product-level scope remains unresolved.
company
Nov.05
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
Indonesia's Influential Islamic Body MUI Urges Vape Permit Freeze, Raising Uncertainty for 200 Manufacturers
Indonesia's Influential Islamic Body MUI Urges Vape Permit Freeze, Raising Uncertainty for 200 Manufacturers
Indonesia's Ulema Council (MUI) published Fatwa No. 131/2026 on November 9, declaring electronic cigarette use, production and trade haram under Islamic religious rules. The council urged the Industry Ministry to prohibit the issuance of vape industry permits and review licensing policies, while calling on the president and parliament to enact a comprehensive ban. On November 10, the Constitutional Court heard a challenge to provisions of the 2023 Health Law seeking a prohibition on vape production, importation, distribution and use. The Health Ministry said on November 11 it was studying stronger restrictions, including a possible ban on circulation, while industry association APVI called for tighter oversight rather than a total ban. Indonesia's Industry Ministry previously estimated the sector comprises about 200 companies, Rp31 trillion ($1.7 billion) in cumulative investment and approximately 100,000 supply-chain jobs. No nationwide statutory ban has been enacted.
Regulations
Nov.12